9 November 2021: The Australian Global Health Alliance is pleased to announce Medicines for Malaria Venture (MMV) as a new Bronze Sponsor.
Medicines for Malaria Venture (MMV) is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs.
Selina Lo, Executive Director of the Australian Global Health Alliance said:
“We are thrilled to have the support of a global player such as MMV during such a critical moment in global health history. As the COVID-19 pandemic continues to challenge our communities and hard won efforts in health over the last decades, it is critical that we, as a global health network, are able to rapidly access and connect to the best possible knowledge, expertise and resources platforms to respond to these current – and future – global health threats.”
“MMV brings a wealth of experience in malaria drug R&D and access, and leadership to the Alliance, and we are looking forward to learning from them and at the same time supporting them to develop new strategic partnerships within Australia and globally. In that regard, we are also equally pleased to welcome Leanne Joyce, Adviser, External Relations at MMV, as incoming Alliance Advisory Board member.”
Dr David Reddy, CEO of MMV said:
“MMV is delighted to sponsor the Australian Global Health Alliance. At MMV, we share the Alliance’s vision of advancing health equity and security. By working with our network of more than 160 global partners, MMV has brought forward 13 malaria therapies estimated to have saved 2.7 million lives.
In Australia, we have 14 research and access partners to accelerate malaria elimination and increase access to lifesaving interventions, including the Partnership for Vivax Elimination (PAVE), together with PATH, Menzies School of Health and the Burnet Institute. We look forward to supporting the Alliance and coordinating actions to improve global health, specifically, towards the eradication of malaria.”
MMV joins a growing list of leading global health institutions supporting the Alliance, including other Bronze Sponsors Deakin University, University of Western Australia and Burnet Institute, and Gold Sponsors University of Melbourne, Monash University, Nossal Institute for Global Health and the CSIRO.